[306 Pages Report] The point of care blood testing devices market is forecasted to be valued at US$ 49,973.6 million by 2032, up from US$ 15,362.4 million in 2022, advancing at a CAGR of 11.3% during the forecast period.
| Report Attribute | Details |
|---|---|
| Point of Care Blood Testing Devices Market Value (2022) | US$ 15,362.4 Million |
| Point of Care Blood Testing Devices Market Anticipated Value (2032) | US$ 49,973.6 Million |
| Point of Care Blood Testing Devices Projected Growth Rate (2022 to 2032) | 11.3% |
There is a drastic increase in the number of people who are opting for self-medication practices, which is likely to boost the sales of point of care testing devices. The demand for point of care blood testing devices is increasing as they are easy to handle and are being used to perform various blood testing devices. They are getting being used to obtain diagnostic tests like blood metabolites, hormone blood tests, protein tests, prothrombin tests, and more.
Therefore, it is anticipated that the point of care blood testing devices market share is likely to witness significant growth during the forecast period of 2022-2032.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for point of care blood testing devices is anticipated to rise as the changing lifestyle of the people has made the population go vigilant about their lifestyle diseases. Due to this, people prefer having the tests done in their household, without the hassle of visiting the diagnostic centres, boosting the sales of point of care blood testing devices.
Due to rising demand for portable monitoring devices, the point of care blood testing devices market share is projected to rise rapidly throughout 2032.
The adoption of point of care blood testing devices especially in the population with chronic conditions is contributing to the growth of the point of care blood testing devices market size.
Moreover, it is anticipated that there is an increased awareness among the population regarding diabetes in adults and children. Therefore, the key drivers boosting the sales of point of care blood testing devices are the increasing incidence of diabetes and different types of medical tests.
Furthermore, technological advances and recent trends in point of care blood testing devices market like point of care blood testing analyser and point of care diabetes analyzers are expected to foster the point of care blood testing devices market expansion.
A significant increase in infectious diseases contributes to the rise in demand for point of care blood testing devices, aiding towards a faster cure, and growing advantages of convenience like portability, transportable test kits, high accuracy levels, and availability of quicker results are likely to drive the point of care blood testing devices market outlook in a positive direction.
Initiatives by government and research grants extended in the developing countries are also to fuel the market and serve as a key driver propelling the sales of point of care blood testing devices during the forecast period.
Although the point of care blood testing devices can be used at a range of locations like emergency departments, healthcare practitioners’ offices, ambulances, accident scenes, emergency departments, and more, a lack of expertise, knowledge, and experience in using these technologies can act as a restraint to the point of care blood testing devices market growth. Furthermore, a high cost of product development is anticipated to slow down the overall expansion of the point of care blood testing devices market.
Depending on the type and nature of the sample or test, the product design needs to consider numerous areas of engineering application and technology. Hence, leads to an integration of the cartridge with the instrument for testing requiring a higher degree of coupling between the two components. This is noted to increase the overall product development cost, thereby impeding the industry landscape.
Moreover, the biomolecules used in developing POC tests are complex in nature and are expensive, which in turn, are anticipated to hamper the point of care blood testing devices market growth.
Principal Consultant
It is anticipated that North America is going to lead the market for point of care blood testing devices. Currently, the North American region contributes 33.4% of the total share of point of care blood testing devices market.
Due to the increasing rate of mortality caused by diabetes in this region and changes in the lifestyle habits people are inclining more toward the adoption of point of care blood testing devices. These factors coupled with an ageing population are expected to boost the market size of point of care blood testing devices over the analysis period.
The European market share is expected to follow the North American regions. Currently, Europe is accountable for 29.4% of the total market share of point of care blood testing devices.
The business landscape in Europe is driven by the expansion of the hospital industry, diagnostic centers, research laboratories and homecare settings in this region. Due to high incidence and prevalence of chronic diseases, there is a surge in the number of hospitalized patients, which is bolstering the market growth of point of care blood testing devices in Europe.
The start-up ecosystem in the point of care blood testing market is intense with frequent innovations being made. Start-ups in the point of care blood testing market are focusing on improvising the devices and techniques of blood testing for faster results and convenience for the patients.
The US-based start-up Hememics develops a point of care platform to rapidly identify infectious disease pathogens. The platform uses a single nasal swab or a drop of blood to test and measure specific antibody and antigen signals. The entire testing process takes under 60 seconds, tests for up to 17 different pathogens, and provides real-time diagnostics to healthcare workers and alerts for health agencies.
Indian start-up Docturnal specializes in the development of a non-invasive point of care diagnostic solution. The low-cost and non-invasive solution uses AI and deep learning for the early and proactive detection of TB biomarkers and symptoms. Singaporean start-up Biosensorix focuses on the development of low-cost and effective point of care blood testing solutions. The start-up’s immune assay-based platform, ELLI, detects biomarkers and pathogens.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the major players in the point of care blood devices testing market are: Abaxis, Abbott Laboratories, Accubiotech Co, Ltd., ACON Laboratories, Inc, Becton, Dickinson and Company, Biolytical Laboratories, Danaher Corporation (HemoCue), Siemens Healthineers and Meridian Bioscience, Inc.
It is anticipated that a strong focus of market players on research & development for innovating new devices incorporating the technological advances aid in the growth of the point of care blood testing devices market.
These market players opt for various inorganic growth strategies such as partnerships, collaborations, mergers, acquisitions, and product launches to create a global footprint and industry competition for point of care blood testing devices.
Key Developments in the Point of Care Blood Testing Devices
Some key developments in the point of care blood testing devices market is:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 11.3% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD million, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The point of care blood testing devices market is predicted to register a CAGR of 11.3% from 2022-to 2032.
North America is anticipated to lead the point of care blood testing devices market.
The point of care blood testing devices market is likely to hold a valuation of US$ 49,973.6 million by 2032.
The healthcare and the diagnostic sector leads the point of care blood testing devices market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Diabetes POC Analyzer
5.3.2. Coagulation POC Analyzer
5.3.3. POC Blood Analyzer
5.3.4. Hematology POC Reader
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
6.3.1. Printer Devices
6.3.2. Touch-Screen Devices
6.3.3. Hand-held Devices
6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021
6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032
7.3.1. Retail Prices
7.3.2. Hospitals
7.3.3. Clinics
7.3.4. Health Centers
7.3.5. Homecare Settings
7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021
7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. US
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Technology
9.2.4. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Technology
9.3.4. By Distribution Channel
9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Technology
10.2.4. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Technology
10.3.4. By Distribution Channel
10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Technology
11.2.4. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Technology
11.3.4. By Distribution Channel
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Rest of Asia Pacific
12.2.2. By Product Type
12.2.3. By Technology
12.2.4. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Technology
12.3.4. By Distribution Channel
12.4. Key Takeaways
13. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.2.3. By Technology
13.2.4. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Technology
13.3.4. By Distribution Channel
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. US
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Type
14.1.2.2. By Technology
14.1.2.3. By Distribution Channel
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Type
14.2.2.2. By Technology
14.2.2.3. By Distribution Channel
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Type
14.3.2.2. By Technology
14.3.2.3. By Distribution Channel
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Type
14.4.2.2. By Technology
14.4.2.3. By Distribution Channel
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Type
14.5.2.2. By Technology
14.5.2.3. By Distribution Channel
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product Type
14.6.2.2. By Technology
14.6.2.3. By Distribution Channel
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product Type
14.7.2.2. By Technology
14.7.2.3. By Distribution Channel
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product Type
14.8.2.2. By Technology
14.8.2.3. By Distribution Channel
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product Type
14.9.2.2. By Technology
14.9.2.3. By Distribution Channel
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product Type
14.10.2.2. By Technology
14.10.2.3. By Distribution Channel
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product Type
14.11.2.2. By Technology
14.11.2.3. By Distribution Channel
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product Type
14.12.2.2. By Technology
14.12.2.3. By Distribution Channel
14.13. GCC Countries
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product Type
14.13.2.2. By Technology
14.13.2.3. By Distribution Channel
14.14. South Africa
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product Type
14.14.2.2. By Technology
14.14.2.3. By Distribution Channel
14.15. Israel
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product Type
14.15.2.2. By Technology
14.15.2.3. By Distribution Channel
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Technology
15.3.4. By Distribution Channel
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. F. Hoffmann-La Roche Ltd
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Getein Biotech
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Abbott Diagnostics
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Callegari Srl
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Goldsite Diagnostics Inc
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. TaiDoc Technology Corporation
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. MED TRUST
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Healthcare
July 2022
REP-GB-6717
333 pages
Explore Healthcare Insights
View Reports
Point Of Care Blood Testing Devices Market
